Journal profile · Oncology
Journal of BUON
ISSN 1107-0625 · Balkan Union of Oncology · GREECE · Quarterly
Journal of BUON: impact factor 1.34; subscription journal; review 4–8 weeks (community reports); community-reported acceptance: easy; 14 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Journal of BUON is published by Balkan Union of Oncology. By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Advanced Radiotherapy Techniques and Cutaneous Melanoma Detection and Management, together about 22.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JBUON aims at the rapid diffusion of scientific knowledge in Oncology. Its character is multidisciplinary, therefore all aspects of oncologic activities are welcome including clinical research (medical oncology, radiation oncology, surgical oncology, nursing oncology, psycho-oncology, supportive care), as well as clinically-oriented basic and laboratory research, cancer epidemiology and social and ethical aspects of cancer. Experts of all these disciplines are included in the Editorial Board. With a rapidly increasing body of new discoveries in clinical therapeutics, the molecular mechanisms that contribute to carcinogenesis, advancements in accurate and early diagnosis etc, JBUON offers a free forum for clinicians and basic researchers to make known promptly their achievements around the world. With this aim JBUON accepts a broad spectrum of articles such as editorials, original articles, reviews, special articles, short communications, commentaries, letters to the editor and correspondence among authors and readers. JBUON keeps the characteristics of its former paper print edition and appears as a bimonthly e-published journal with continuous volume, issue and page numbers.
Source: LetPub
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology11.1%
- Advanced Radiotherapy TechniquesPhysics and Astronomy5.6%
- Cutaneous Melanoma Detection and ManagementMedicine5.6%
- Ovarian cancer diagnosis and treatmentMedicine5.6%
- Endometrial and Cervical Cancer TreatmentsMedicine5.6%
- Breast Lesions and CarcinomasMedicine5.6%
- Melanoma and MAPK PathwaysBiochemistry, Genetics and Molecular Biology5.6%
- MRI in cancer diagnosisMedicine5.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.34LetPub ·
- CiteScore 2026-06
- 0LetPub ·
- SJR 2026-06
- 0.1LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 22LetPub ·
- h-index
- 2OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0.21OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 376LetPub ·
Articles by year OpenAlex count · 33 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2025 | 14 | 11 | 3 |
| 2021 | 2 | 2 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Balkan Union of Oncology
- Country or region
- GREECE
- Language
- English
- Frequency
- Quarterly
- ISSN
- 1107-0625
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of BUON
What is the impact factor of Journal of BUON?
The latest impact factor listed by LetPub is 1.34; CiteScore 0, h-index 2.
How long does peer review take at Journal of BUON?
Authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of BUON?
According to LetPub and DOAJ records, Journal of BUON is indexed in Scopus.
Is Journal of BUON open access, and what is the APC?
Journal of BUON is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .